Literature DB >> 20969508

Adrenal lesion frequency: A prospective, cross-sectional CT study in a defined region, including systematic re-evaluation.

Lilian Hammarstedt1, Andreas Muth, Bo Wängberg, Lena Björneld, Helga A Sigurjónsdóttir, Galina Götherström, Erik Almqvist, Håkan Widell, Sture Carlsson, Stefan Ander, Mikael Hellström.   

Abstract

BACKGROUND: incidentally detected adrenal lesions have become a growing clinical problem.
PURPOSE: to prospectively estimate and validate the prevalence of incidentally detected adrenal lesions (adrenal incidentaloma) in patients with or without malignant disease undergoing CT.
MATERIAL AND METHODS: during 18 months all adult patients with incidentally discovered adrenal lesions detected at CT were prospectively reported from the radiology departments of all hospitals in Western Sweden (1.66 million inhabitants). Frequencies of adrenal lesions initially reported at CT and at a systematic re-evaluation were compared. The interobserver variation in blindly assessing adrenal lesions was also analyzed.
RESULTS: adrenal lesions were reported and verified in 339 patients (193 females; mean age 69 years, range 30-94 years). Mean lesion size was 25.8 mm (range 8-94 mm). The mean frequency of originally reported adrenal lesions was 0.9% (range 0-2.4% between hospitals). The systematic re-evaluation of 3801 randomly selected cases showed a mean frequency of 4.5% (range 1.8-7.1% between hospitals). The re-evaluation revealed 177 cases with adrenal lesions, 30% of these were submitted by the local radiologist in accordance with the study design, 23% were described in the local radiology report but not submitted to the study center, while 47% were neither locally reported nor submitted.
CONCLUSION: adrenal lesions are under-reported in clinical practice. Prevalence figures for adrenal incidentalomas should therefore be interpreted with caution, especially in multi-center settings.

Entities:  

Mesh:

Year:  2010        PMID: 20969508     DOI: 10.3109/02841851.2010.516016

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  16 in total

Review 1.  The indeterminate adrenal mass.

Authors:  Barney Harrison
Journal:  Langenbecks Arch Surg       Date:  2011-09-23       Impact factor: 3.445

2.  Low investigation rate for adrenal incidentalomas.

Authors:  S Bujawansa; D Bowen-Jones
Journal:  Endocrine       Date:  2011-05-12       Impact factor: 3.633

3.  Risk estimator for adrenal tumor functionality.

Authors:  Claire Sadler; Melanie Goldfarb
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

4.  NP-59 test for preoperative localization of primary hyperaldosteronism.

Authors:  Marcello Di Martino; Iñigo García Sanz; Jose Luis Muñoz de Nova; Cristina Marín Campos; Miguel Martínez Martín; Luis Domínguez Gadea
Journal:  Langenbecks Arch Surg       Date:  2017-02-21       Impact factor: 3.445

5.  Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms.

Authors:  Dhaval Patel; Matthew D Thompson; Soumen K Manna; Kristopher W Krausz; Lisa Zhang; Naris Nilubol; Frank J Gonzalez; Electron Kebebew
Journal:  Clin Cancer Res       Date:  2017-04-27       Impact factor: 12.531

Review 6.  Molecular imaging of adrenal neoplasms.

Authors:  Clara C Chen; Jorge A Carrasquillo
Journal:  J Surg Oncol       Date:  2012-05-24       Impact factor: 2.885

7.  Laparoscopic sleeve gastrectomy with adrenalectomy, feasibility, safety and outcome.

Authors:  Awadh Alqahtani; Mohammad Almayouf; Srikar Billa; Hadeel Helmi
Journal:  J Surg Case Rep       Date:  2022-05-05

8.  Bilateral Adrenal Incidentalomas: A Rare Presentation of Lung Cancer.

Authors:  Halit Diri; Melih Kiziltepe; Sulbiye Karaburgu; Mehmet Sait Koc; Ersin Ozaslan; Fatih Tanriverdi
Journal:  Case Rep Endocrinol       Date:  2015-05-26

Review 9.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

10.  Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma.

Authors:  Stefano Caramuta; Linkiat Lee; Deniz M Ozata; Pinar Akçakaya; Hong Xie; Anders Höög; Jan Zedenius; Martin Bäckdahl; Catharina Larsson; Weng-Onn Lui
Journal:  Endocr Relat Cancer       Date:  2013-07-04       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.